Dhruvi Pharma Profile
Key Indicators
- Authorised Capital ₹ 9.65 Cr
as on 18-01-2025
- Paid Up Capital ₹ 1.56 Cr
as on 18-01-2025
- Company Age 23 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 57.75 Cr
as on 18-01-2025
- Revenue 22.17%
(FY 2023)
- Profit -34.94%
(FY 2023)
- Ebitda 20.74%
(FY 2023)
- Net Worth -16.63%
(FY 2023)
- Total Assets -73.18%
(FY 2023)
About Dhruvi Pharma
- CIN/LLPIN
U24231TS2001PTC171830
- Company No.
039783
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2001
- Date of AGM
01 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Dhruvi Pharma Private Limited offer?
Dhruvi Pharma Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Pharmaceutical Chemists, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Anti Infective Drugs & Medicines, Remdesivir Injection.
Who are the key members and board of directors at Dhruvi Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupesh Shah  | Managing Director | 16-Jul-2001 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Venkat | Nominee Director | 09-Mar-2015 | Current |
| Deeptiben Shah | Director | 16-Jul-2001 | Current |
| Yashwant Singh | Nominee Director | 03-Jul-2018 | Current |
Financial Performance of Dhruvi Pharma.
Dhruvi Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.17% increase. The company also saw a substantial fall in profitability, with a 34.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhruvi Pharma?
In 2022, Dhruvi Pharma had a promoter holding of 30.00% and a public holding of 70.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neelkanth Drugs Private LimitedActive 25 years 9 monthsArvind Venkat and Yashwant Singh are mutual person
Yashvi Distribution Services Private LimitedActive 20 years 10 monthsRupesh Shah and Deeptiben Shah are mutual person
- Yashvi Pharma Private LimitedActive 21 years 8 months
Rupesh Shah and Deeptiben Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Sep 2016 | ₹1.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 26 Feb 2015 | ₹50.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 29 Sep 2011 | ₹5.25 Cr | Satisfied |
How Many Employees Work at Dhruvi Pharma?
Dhruvi Pharma has a workforce of 375 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhruvi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhruvi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
